Tag: Sibutramine [Reductil]

By Posted on Posted in Market Withdrawal Tagged with , , ,

October 08, 2010 – Today, we learn that Abbott Laboratories and FDA notified healthcare professionals and patients about the voluntary market withdrawal of Sibutramine [Meridia], an obesity drug, from the U.S. market because of clinical trial data indicating an increased …

Sibutramine [Meridia]: Market Withdrawal Due to Risk of Serious Cardiovascular events Read more »

By Posted on Posted in Adverse Drug Reaction [ADR], Dietary Ingredients Tagged with , , , , , , , , ,

July 11, 2010 – Do the people behind such products at all know what they do? On July 08, 2010, the FDA has issued the following warning concerning the Que She Herbal Supplement and its Undeclared Drug Ingredients: AUDIENCE: Consumer, …

Que She Herbal Supplement Has It All: Undeclared Drug Ingredients Fenfluramine, Propranolol, Sibutramine, Ephedrine Read more »